Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments [Yahoo! Finance]
NORTHWEST BIOTHRPUTCS INC (NWBO)
US:NASDAQ Investor Relations:
nwbio.com/investors-media
Company Research
Source: Yahoo! Finance
DCVax® personalized immune therapies for solid tumor cancers, announced that Dr. Marnix Bosch , its Chief Technical Officer, will make a presentation on "Next Generation Dendritic Cell Treatments to Improve Anti-Tumor Responses" at the upcoming Frontiers in Cancer Immunotherapy Conference of the New York Academy of Sciences. Dr. Bosch will address certain factors and combinations of factors that may lead to supercharged dendritic cells with enhanced anti-tumor effects. The presentation will take place on Monday, June 16 , at 2:50 p.m. The slides will be posted on the Company's website after the presentation. About Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products that are designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company has a broad platform technology for DCVax ® dendrit
Show less
Read more
Impact Snapshot
Event Time:
NWBO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NWBO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NWBO alerts
High impacting NORTHWEST BIOTHRPUTCS INC news events
Weekly update
A roundup of the hottest topics
NWBO
News
- Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK FacilityPR Newswire
- Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK FacilityPR Newswire
- Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has ClosedPR Newswire
- Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has ClosedPR Newswire
NWBO
Sec Filings
- 11/28/25 - Form DEF
- 11/26/25 - Form EFFECT
- 11/25/25 - Form 424B5
- NWBO's page on the SEC website